Today’s top gainers include the company Gilead Sciences Inc. (NASDAQ:GILD) which is in the industry Biotechnology, gaining 1.49% today. In the last week its performance is -0.14%, and -14.61% for the past quarter. Currently, Gilead Sciences Inc., GILD has a target price of 110.37, so today’s gain of 1.49% is a significant step towards its target price. The GAP today is therefore 0.02%.
Gilead Sciences Inc. (NASDAQ:GILD), has a market cap of 116188.19, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 81.90%.
At the current price of 87.84, it has a dividend yield of 2.17%, and its target price is 110.37. This is with a profit margin of 52.80%, and total debt/equity of 1.7. Gilead Sciences Inc. (NASDAQ:GILD) has a P/E of 7.4, as well as a forward P/E of 7.04.
With a current EPS of 11.69, and a forecasted EPS growth for next year at 2.29%,Gilead Sciences Inc. (NASDAQ:GILD) has had a EPS growth for the past five years at 48.30%. For the next five years EPS growth is projected to be 0.79%.
Performance for the year is -25.06%. Since its IPO date on 1/22/1992, the total performance to date is -13.57%.
Volume today for Gilead Sciences Inc. (NASDAQ:GILD), is 5665609, while its average volume is 9443.03. Whilst the total gain today was 1.49%, it did have a day high of -0.14%.
Volatility for this week has been at 1.68%, and 2.05% for the month. The 52-week low for Gilead Sciences Inc., GILD has been 12.73%, while the 52-week-high has reached -25.65%.
Looking at its return of investments, which is 45.90%, and its return on assets is 36.60%. Gilead Sciences Inc. (NASDAQ:GILD) has an operating margin of 65.40%. With a sales growth of 2.60% quarter over quarter. Bearing in mind that Gilead Sciences Inc., GILD is in the sector Healthcare, its long-term debt/equity is 1.57, and has a current ratio of 1.8 and 1.6 for quick ratio.
So what is the value of Gilead Sciences Inc.? Well its PEG is 9.43, and the P/S is 3.54, along with a P/B of 8.93. Meanwhile it has a p/cash of 13.97.